Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariella Martorelli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
ACS Pharmacology & Translational Science|June 16, 2023
Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α RatioJulian Laux, Mariella Martorelli, Nadja Späth, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Inherent Fluorescence Demonstrates Immunotropic Properties for Novel Janus Kinase 3 InhibitorsJulian Laux, Mariella Martorelli, Simon Strass, et al.
Journal of Medicinal Chemistry|May 11, 2021
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase InhibitorsNiklas M Tormählen, Mariella Martorelli, Annette Kuhn, et al.
Neuropharmacology|December 22, 2015
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135Maria Antonietta De Luca, M Paola Castelli, Barbara Loi, et al.
Inflammopharmacology|April 2, 2023
Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivoSimon Straß, Johanna Geiger, Natascha Cloos, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Inflammopharmacology|March 21, 2023
Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease modelsSimon Straß, Johanna Geiger, Mariella Martorelli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
ACS Pharmacology & Translational Science|June 16, 2023
Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α RatioJulian Laux, Mariella Martorelli, Nadja Späth, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Inherent Fluorescence Demonstrates Immunotropic Properties for Novel Janus Kinase 3 InhibitorsJulian Laux, Mariella Martorelli, Simon Strass, et al.
Journal of Medicinal Chemistry|May 11, 2021
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase InhibitorsNiklas M Tormählen, Mariella Martorelli, Annette Kuhn, et al.
Neuropharmacology|December 22, 2015
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135Maria Antonietta De Luca, M Paola Castelli, Barbara Loi, et al.
Inflammopharmacology|April 2, 2023
Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivoSimon Straß, Johanna Geiger, Natascha Cloos, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Inflammopharmacology|March 21, 2023
Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease modelsSimon Straß, Johanna Geiger, Mariella Martorelli, et al.
Pageof 1